Analysis of glycoprotein E-selectin ligANDs on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells
Burdick, Monica M.
Dagia, Nilesh M.
Chu, Julia T.
Fuhlbrigge, Robert C.
Sackstein, Robert D.
KAUST DepartmentBiological and Environmental Sciences and Engineering (BESE) Division
Permanent link to this recordhttp://hdl.handle.net/10754/565953
MetadataShow full item record
AbstractAlthough well recognized that expression of E-selectin on marrow microvessels mediates osteotropism of hematopoietic stem/progenitor cells (HSPCs), our knowledge regarding the cognate E-selectin ligand(s) on HSPCs is incomplete. Flow cytometry using E-selectin-Ig chimera (E-Ig) shows that human marrow cells enriched for HSPCs (CD34+ cells) display greater E-selectin binding than those obtained from mouse (lin-/Sca-1+/c-kit+ [LSK] cells). To define the relevant glycoprotein E-selectin ligands, lysates from human CD34+ and KG1a cells and from mouse LSK cells were immunoprecipitated using E-Ig and resolved byWestern blot using E-Ig. In both human and mouse cells, E-selectin ligand reactivity was observed at ∼ 120- to 130-kDa region, which contained two E-selectin ligands, the P-selectin glycoprotein ligand- 1 glycoform "CLA," and CD43. Human, but not mouse, cells displayed a prominent ∼ 100-kDa band, exclusively comprising the CD44 glycoform "HCELL."E-Ig reactivity was most prominent on CLA in mouse cells and on HCELL in human cells. To further assess HCELL's contribution to E-selectin adherence, complementary studies were performed to silence (via CD44 siRNA) or enforce its expression (via exoglycosylation). Under physiologic shear conditions, CD44/HCELL-silenced human cells showed striking decreases (> 50%) in E-selectin binding. Conversely, enforced HCELL expression of LSK cells profoundly increased E-selectin adherence, yielding > 3-fold more marrow homing in vivo. These data define the key glycoprotein E-selectin ligands of human and mouse HSPCs, unveiling critical species-intrinsic differences in both the identity and activity of these structures. © 2011 by The American Society of Hematology.
PublisherAmerican Society of Hematology
PubMed Central IDPMC3158712
- The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives.
- Authors: Sackstein R
- Issue date: 2011 Jul
- differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1.
- Authors: Dimitroff CJ, Lee JY, Schor KS, Sandmaier BM, Sackstein R
- Issue date: 2001 Dec 14
- HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
- Authors: Burdick MM, Chu JT, Godar S, Sackstein R
- Issue date: 2006 May 19
- Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.
- Authors: Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R
- Issue date: 2008 Feb
- CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
- Authors: Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R
- Issue date: 2005 Jul 1